FDA Panel Finds Tiotropium Safe for COPD Patients

Courtesy MedPage Today Allergy & Immunology  Fri, 11/20/2009 - 11:42

An FDA committee said new data allay concerns about the risk of stroke and cardiovascular events previously associated with tiotropium (Spiriva), drugmaker Boehringer Ingelheim said.

Tags:

 

More related items

FDA Panel Split Over Inhaled Antipsychotic
WASHINGTON (MedPage Today) -- An FDA advisory panel punted on the question of approval for an inhaled version of the antipsychotic drug loxapine (Adasuve) to treat agitation in bipolar and...

FDA: Stronger Labeling Needed for Newer Contraceptives
An FDA panel voted 15-11 that the benefits of newer oral contraceptives outweigh their risks of dangerous blood clots.

FDA Panel Rejects Champion Monitor
WASHINGTON (MedPage Today) -- An FDA advisory panel overwhelmingly agreed that an implantable pulmonary artery pressure monitoring device was safe, but was not convinced about its...

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com